Report of the Working Party Group on Determining the Radionuclide of Choice.

Blaufox, M D; Dubovsky, E V; Hilson, A J; Taylor, A; de Zeeuw, R

Blaufox, M D; Dubovsky, E V; Hilson, A J; Taylor, A; de Zeeuw, R.

Affiliation

Blaufox MD; Albert Einstein College of Medicine, Bronx, NY 10461.

Am J Hypertens ; 4(12 Pt 2): 747S-748S, 1991 Dec.

Article in En | MEDLINE | ID: mdl-1777190

ABSTRACT

ABSTRACT

There are a variety of radiopharmaceuticals that can be used to perform captopril renography effectively. We examined a number of technetium and iodine compounds and the circumstances under which each radiopharmaceutical compound is the compound of choice. Considerations of cost, ease of use, reliability, dosage, and the effects of different protocols were all examined.

Subject(s)

Captopril; Hypertension, Renovascular/diagnostic imaging; Iodine Radioisotopes; Organotechnetium Compounds; Radioisotope Renography/methods; Humans; Iodohippuric Acid

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Captopril / Radioisotope Renography / Organotechnetium Compounds / Hypertension, Renovascular / Iodine Radioisotopes Type of study: Guideline Limits: Humans Language: En Journal: Am J Hypertens Journal subject: ANGIOLOGIA Year: 1991 Type: Article

Search on Google

XML

PubMed Links